Simulations Plus, Inc. (SLP)
| Market Cap | 367.24M |
| Revenue (ttm) | 79.18M |
| Net Income (ttm) | -64.72M |
| Shares Out | 20.14M |
| EPS (ttm) | -3.22 |
| PE Ratio | n/a |
| Forward PE | 35.33 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 153,454 |
| Open | 18.19 |
| Previous Close | 18.23 |
| Day's Range | 18.01 - 18.37 |
| 52-Week Range | 12.39 - 37.67 |
| Beta | 1.17 |
| Analysts | Buy |
| Price Target | 27.25 (+49.48%) |
| Earnings Date | Jan 8, 2026 |
About SLP
Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. It operates through Software and Services segments. The company offers GastroPlus, which predicts absorption, biopharmaceutics, pharmacokinetics, and pharmacodynamics in humans and animals; and DDDPlus and MembranePlus simulation products. It also provides products based on mechanistic and mathematical models, such as DILIsym... [Read more]
Financial Performance
Financial StatementsAnalyst Summary
According to 7 analysts, the average rating for SLP stock is "Buy." The 12-month stock price target is $27.25, which is an increase of 49.48% from the latest price.
News
Simulations Plus to Host Virtual Investor Day Highlighting Strategy for the Next Era of Model-Informed Drug Development
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus” or the “Company”), a global leader in model-informed and AI-accelerated drug development that ad...
Simulations Plus Announces First Quarter Fiscal Year 2026 Earnings and Conference Call Date
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus”, “SLP”), a global leader in model-informed and AI-accelerated drug development that advances bio...
Simulations Plus Positioned to Capitalize on FDA's Streamlined Nonclinical Safety Guidance with Advanced Mechanistic and Model-Informed Solutions
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus” or the “Company”), a global leader in model-informed and AI-accelerated drug development that ad...
Simulations Plus: Buying On Long-Term Silico Drug-Development
Simulations Plus is a specialized in silico software-and-services platform. They help with model-informed, non-animal drug development. SLP's services help across discovery, development, and clinical ...
Simulations Plus Stock Climbs On Earnings Strength, Biotech Market Rebound
Simulations Plus Inc. (NASDAQ: SLP) shares climbed on Tuesday after the company reported better-than-expected fourth-quarter 2025 earnings and reaffirmed annual guidance.
Simulations Plus, Inc. (SLP) Q4 2025 Earnings Call Transcript
Simulations Plus, Inc. (SLP) Q4 2025 Earnings Call Transcript
Simulations Plus Reports Fourth Quarter and Fiscal 2025 Financial Results
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus” or the “Company”), a global leader in cheminformatics, biosimulation, clinical operations soluti...
SIMULATIONS PLUS INVESTIGATION: Bragar Eagel & Squire, P.C. Urges Simulations Plus Investors to Contact the Firm Regarding Their Rights
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Simulations Plus (SLP) To Contact Him Directly To Discuss Their Options If you purchased or...
SLP INVESTORS: Simulations Plus, Inc. Hit with Securities Fraud Investigation after Stock Plummets 26% -- Investors Urged to Contact BFA Law
NEW YORK, Oct. 24, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Simulations Plus, Inc. (NASDAQ: SLP) for potential violations of the ...
Simulations Plus Announces Preliminary Fiscal Year 2025 Results and Fiscal Year 2026 Guidance
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus” or the “Company”), a leading provider of cheminformatics, biosimulation, simulation-enabled perf...
SLP STOCK NOTICE: Simulations Plus, Inc. Investors with Losses may have been Affected by Securities Fraud – Contact BFA Law about its Pending Investigation
NEW YORK, Oct. 22, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Simulations Plus, Inc. (NASDAQ: SLP) for potential violations of the...
SLP SECURITIES NEWS: Simulations Plus, Inc. Faces a Securities Fraud Investigation after Stock Drops 26% -- Contact BFA Law if You Suffered Losses
NEW YORK, Oct. 20, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Simulations Plus, Inc. (NASDAQ: SLP) for potential violations of the ...
SLP SECURITIES NOTICE: Simulations Plus, Inc. Securities Fraud Investigation is Pending – Contact BFA Law if You Lost Money
NEW YORK, Oct. 10, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Simulations Plus, Inc. (NASDAQ: SLP) for potential violations of the ...
SLP FRAUD NOTICE: Simulations Plus, Inc. Hit with Securities Fraud Investigation Due to Impairment Charges -- Contact BFA Law if You Suffered Losses
NEW YORK, Oct. 08, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Simulations Plus, Inc. (NASDAQ: SLP) for potential violations of the ...
SLP SHAREHOLDER NOTICE: Simulations Plus, Inc. Investigated for Securities Fraud after 26% Stock Drop – Contact BFA Law
NEW YORK, Oct. 06, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Simulations Plus, Inc. (NASDAQ: SLP) for potential violations of the...
Johnson Fistel Investigates Simulations Plus Following Reports of Financial and Internal Control Issues
SAN DIEGO, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP announces that it is investigating potential claims on behalf of investors of Simulations Plus, Inc. (NASDAQ: SLP) regarding possible ...
Simulations Plus (SLP) Faces Investor Scrutiny After Asset Impairment and Auditor Firing-- Hagens Berman
SAN FRANCISCO, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Hagens Berman has launched an investigation into Simulations Plus, Inc. (NASDAQ: SLP) after the company's stock price plummeted approximately 25% on J...
SLP SECURITIES NEWS: Why did Simulations Plus, Inc. Stock Drop 26%? Investors with Losses Reminded to Contact BFA Law
NEW YORK, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Simulations Plus, Inc. (NASDAQ: SLP) for potential violations of the...
The Bottom Fishing Club - Simulations Plus: Huge Potential In AI Drug Discovery
Simulations Plus appears to be a unique Buy candidate, driven by an ultra-low valuation and the potential for AI-inspired growth in drug discovery modeling. The FDA Modernization Act 2.0 and industry ...
SLP SECURITIES NOTICE: Did Simulations Plus, Inc. Mislead Investors? Contact BFA Law if You Lost Money on Your Investment
NEW YORK, Sept. 12, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Simulations Plus, Inc. (NASDAQ: SLP) for potential violations of the...
Simulations Plus, Inc. (SLP) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)
Simulations Plus, Inc. (NASDAQ:SLP) Morgan Stanley 23rd Annual Global Healthcare Conference September 10, 2025 2:35 PM EDT Company Participants Shawn O'Connor - Chief Executive Officer Presentation U...
SLP FRAUD NOTICE: Simulations Plus, Inc. Hit with Securities Fraud Investigation after 26% Stock Drop – Investors Urged to Contact BFA Law
NEW YORK, Sept. 10, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Simulations Plus, Inc. (NASDAQ: SLP) for potential violations of the...
SLP SHAREHOLDERS: Simulations Plus, Inc. Investors may have been Affected by Fraud – Contact BFA Law if You Lost Money (NASDAQ:SLP)
NEW YORK, Aug. 29, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Simulations Plus, Inc. (NASDAQ: SLP) for potential violations of the ...
Simulations Plus to Participate in Upcoming Investor Conferences
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus”, “SLP”), a leading provider of cheminformatics, biosimulation, simulation-enabled performance an...
SLP INVESTOR NOTIFICATION: Simulations Plus, Inc. Investors are Urged to Contact BFA Law about the Pending Securities Fraud Investigation (NASDAQ:SLP)
NEW YORK, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Simulations Plus, Inc. (NASDAQ: SLP) for potential violations of the ...